Consolidated Trial Balance
Explain each group balance through translated inputs, the reviewed closing CTA effect, retained elimination and reversal history, supported allocation entries and approved top-sides.
Review group-only adjustments and build statements with a traceable financial basis.
Visible to: Group Controller / Corporate CFO. Visibility does not establish approval authority.
Approval conditions.
A top-side adjustment records the affected account, offset account, signed amount, period and reason. Attach the supporting workpaper before submission. The signed amount produces equal and opposite effects on the two declared accounts; the consolidated build must include both sides, not add the same amount to every account.
The Group Controller reviews the current revision independently of preparation. Approval freezes the evidence and amount. A submitted edit invalidates the earlier decision. These entries belong to the consolidation layer and leave the subsidiary’s source books unchanged unless a separately authorised source-ledger correction is made.
The calculation uses the approved ownership method, effective interval and allocation basis. For the configured simple common-equity case, the non-controlling percentage is one hundred less the parent share, applied to the reviewed equity and income bases. Different share rights, acquisition adjustments or mid-period ownership changes require the appropriate reviewed workpaper.
Keep allocation amounts and their offset classifications separate from the translated source balances. An allocation reclassifies supported balances; it does not add the same subsidiary equity a second time. The group result records the chosen ownership version and explains the amount attributable to the parent and other owners.
The consolidated trial balance combines the chosen run’s translated balances, closing translation adjustment, posted elimination history with linked reversals, approved adjustment effects and supported allocation entries. It rejects a mixture of outputs from different input snapshots. Account-level drill-down shows where each component came from and preserves debit and credit signs.
A balanced total is an essential check but cannot prove that all entities, mappings or disclosures are correct. Complete the population, rate and exception checks as well. A missing subsidiary can leave a numerically balanced group result; the frozen required-entity set is what prevents that result from being treated as complete.
Income statement and balance sheet lines use reviewed group-account mappings. The cash flow statement also requires classified movement information and non-cash, acquisition, disposal and currency-effect reconciliations. Comparing two closing trial balances alone cannot explain every cash movement. Missing movement evidence keeps the statement in draft.
The equity roll-forward reconciles opening balances, profit, distributions, ownership movements and other comprehensive income to the closing balances. Supporting movement records retain source evidence, classification, amount and review. Narrative disclosures use the same reporting period and selected financial revision, so a pack cannot combine a new number with an older approved note.
A preparer creates the candidate statements and notes. The Consolidation Manager reviews the reconciled output; the Group Controller signs the approved revision before publication. Working reports can support the review without giving executive readers access to unpublished balances. A correction after publication creates a linked restatement and preserves the original pack, its signatures and the financial inputs that explain it.
Keep the reporting group, ownership changes and account mappings ready for the next close.
Collect complete subsidiary balances and resolve exceptions before group calculation.
Translate accepted balances using reviewed rates and explain the currency movement.
Match both sides of intercompany activity and retain an explanation for every difference.
Review group-only adjustments and build statements with a traceable financial basis.
Publish the reviewed close and give each reader the evidence they are allowed to see.
Explain each group balance through translated inputs, the reviewed closing CTA effect, retained elimination and reversal history, supported allocation entries and approved top-sides.
| Balance Number | Consolidation Account | Translated Subtotal USD | CTAAmount USD | Eliminations USD |
|---|---|---|---|---|
| CTB-59395 | CCA-6184 | 330 | 870 | 110 |
| CTB-41681 | CCA-8430 | 960 | 390 | 270 |
| CTB-45811 | CCA-5800 | 160 | 200 | 890 |
| CTB-86159 | CCA-5223 | 840 | 200 | 280 |
| CTB-65204 | CCA-9916 | 870 | 310 | 280 |
| CTB-52854 | CCA-1374 | 220 | 60 | 570 |
Compare reviewed period and cumulative group results with the approved parent and non-controlling allocation.
| Balance Number | Consolidation Account | Translated Subtotal USD | CTAAmount USD | Eliminations USD |
|---|---|---|---|---|
| CTB-59395 | CCA-6184 | 330 | 870 | 110 |
| CTB-41681 | CCA-8430 | 960 | 390 | 270 |
| CTB-45811 | CCA-5800 | 160 | 200 | 890 |
| CTB-86159 | CCA-5223 | 840 | 200 | 280 |
| CTB-65204 | CCA-9916 | 870 | 310 | 280 |
| CTB-52854 | CCA-1374 | 220 | 60 | 570 |
Reconcile group assets, liabilities and equity at the selected published revision.
| Balance Number | Consolidation Account | Translated Subtotal USD | CTAAmount USD | Eliminations USD |
|---|---|---|---|---|
| CTB-59395 | CCA-6184 | 330 | 870 | 110 |
| CTB-41681 | CCA-8430 | 960 | 390 | 270 |
| CTB-45811 | CCA-5800 | 160 | 200 | 890 |
| CTB-86159 | CCA-5223 | 840 | 200 | 280 |
| CTB-65204 | CCA-9916 | 870 | 310 | 280 |
| CTB-52854 | CCA-1374 | 220 | 60 | 570 |
Explain cash changes with reviewed operating, investing, financing, currency and non-cash movement evidence.
| Balance Number | Consolidation Account | Translated Subtotal USD | CTAAmount USD | Eliminations USD |
|---|---|---|---|---|
| CTB-59395 | CCA-6184 | 330 | 870 | 110 |
| CTB-41681 | CCA-8430 | 960 | 390 | 270 |
| CTB-45811 | CCA-5800 | 160 | 200 | 890 |
| CTB-86159 | CCA-5223 | 840 | 200 | 280 |
| CTB-65204 | CCA-9916 | 870 | 310 | 280 |
| CTB-52854 | CCA-1374 | 220 | 60 | 570 |
Tie opening equity and translation adjustment through supported movements to the closing balances.
| Balance Number | Consolidation Account | Translated Subtotal USD | CTAAmount USD | Eliminations USD |
|---|---|---|---|---|
| CTB-59395 | CCA-6184 | 330 | 870 | 110 |
| CTB-41681 | CCA-8430 | 960 | 390 | 270 |
| CTB-45811 | CCA-5800 | 160 | 200 | 890 |
| CTB-86159 | CCA-5223 | 840 | 200 | 280 |
| CTB-65204 | CCA-9916 | 870 | 310 | 280 |
| CTB-52854 | CCA-1374 | 220 | 60 | 570 |
Show adjustment and offset accounts, amounts, preparers, reviewers and retained evidence at the chosen period revision.
Approval conditions.
Review all authorised group financial records.
Review all authorised group financial recordsIndependently approve OwnershipChanges, TopSideAdjustments, MinorityInterest workpapers, ConsolidationMovements and DisclosuresSign and publish ConsolidatedFinancialsAuthorise a reasoned new restatement revisionApproval conditions.
Prepare imported SubsidiaryTrialBalances and draft TrialBalanceLines.
Prepare imported SubsidiaryTrialBalances and draft TrialBalanceLinesPrepare FXRates, IntercompanyTransactions, Eliminations, TopSideAdjustments, ConsolidationMovements and DisclosuresInvestigate exceptions and view authorised group working reportsNo acceptance, independent approval, publication or unrestricted source-ledger accessRead published ConsolidatedFinancials, approved published Disclosures and their BoardPackExports.
Read published ConsolidatedFinancials, approved published Disclosures and their BoardPackExportsView only published aggregate ConsolidatedTrialBalanceNo signed unpublished files, source entity details or financial actionsBring accepted subsidiary balances and approved translation inputs into one complete group calculation.
6 stages · 3 approvals
Resolve reciprocal source differences before posting a balanced consolidation-layer elimination.
3 stages · 2 approvals
Carry the approved effective ownership basis into translated, allocated group results.
4 stages · 2 approvals
Create your ERP.AI account and get started with Proto.
We use essential cookies to run the site and optional cookies for features, analytics, and relevant content. See Cookie policy
We use cookies to enhance your experience, analyze site traffic, and serve relevant content. By clicking "Accept All," you agree to our use of cookies. You can customize your preferences at any time.
Learn more about how we use cookiesThese cookies are required for the website to function properly. They ensure security, enable basic features like page navigation, and store user session data. You cannot disable these cookies.
These cookies enable additional features that enhance your experience, such as live chat, video playback, personalized content recommendations, and remembering user preferences.
These cookies help us understand how visitors interact with our site by collecting anonymous usage data. This allows us to measure performance, detect issues, and continuously improve the user experience.
These cookies allow us and advertising partners, including X, to deliver ads tailored to your interests. They track browsing habits across sites to provide relevant advertising and measure ad effectiveness.